Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Zuber

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Veterinary Microbiology|May 15, 2007
Therapeutic approaches targeting the prion receptor LRP/LRChantal Zuber, Heike Ludewigs, Stefan Weiss
Cellular and Molecular Neurobiology|December 8, 2006
Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapyKaren Vana, Chantal Zuber, Daphne Nikles, et al.
Journal of Hematology & Oncology|January 13, 2017
Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studiesKurt Schönfeld, Chantal Zuber, Jan Pinkas, et al.
Expert Review of Anti-Infective Therapy|August 7, 2007
Therapeutic approaches for prion disordersHeike Ludewigs, Chantal Zuber, Karen Vana, et al.
Prion|January 24, 2009
Anti-LRP/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected miceChantal Zuber, Gerda Mitteregger, Claudia Pace, et al.
Pharmaceutical Research|April 19, 2018
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor ModelsKurt Schönfeld, Peter Herbener, Chantal Zuber, et al.
Infectious Disorders Drug Targets|February 10, 2009
LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancerKaren Vana, Chantal Zuber, Heike Pflanz, et al.
Circulation. Cardiovascular Interventions|September 23, 2016
Evolution of Cognitive Function After Transcatheter Aortic Valve ImplantationAndreas W Schoenenberger, Chantal Zuber, André Moser, et al.
Journal of Molecular Biology|July 7, 2010
Prion interaction with the 37-kDa/67-kDa laminin receptor on enterocytes as a cellular model for intestinal uptake of prionsDominika Kolodziejczak, Bianca Da Costa Dias, Chantal Zuber, et al.
Molecular Immunology|June 20, 2007
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseasesChantal Zuber, Stefan Knackmuss, Clémence Rey, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Veterinary Microbiology|May 15, 2007
Therapeutic approaches targeting the prion receptor LRP/LRChantal Zuber, Heike Ludewigs, Stefan Weiss
Cellular and Molecular Neurobiology|December 8, 2006
Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapyKaren Vana, Chantal Zuber, Daphne Nikles, et al.
Journal of Hematology & Oncology|January 13, 2017
Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studiesKurt Schönfeld, Chantal Zuber, Jan Pinkas, et al.
Expert Review of Anti-Infective Therapy|August 7, 2007
Therapeutic approaches for prion disordersHeike Ludewigs, Chantal Zuber, Karen Vana, et al.
Prion|January 24, 2009
Anti-LRP/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected miceChantal Zuber, Gerda Mitteregger, Claudia Pace, et al.
Pharmaceutical Research|April 19, 2018
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor ModelsKurt Schönfeld, Peter Herbener, Chantal Zuber, et al.
Infectious Disorders Drug Targets|February 10, 2009
LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancerKaren Vana, Chantal Zuber, Heike Pflanz, et al.
Circulation. Cardiovascular Interventions|September 23, 2016
Evolution of Cognitive Function After Transcatheter Aortic Valve ImplantationAndreas W Schoenenberger, Chantal Zuber, André Moser, et al.
Journal of Molecular Biology|July 7, 2010
Prion interaction with the 37-kDa/67-kDa laminin receptor on enterocytes as a cellular model for intestinal uptake of prionsDominika Kolodziejczak, Bianca Da Costa Dias, Chantal Zuber, et al.
Molecular Immunology|June 20, 2007
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseasesChantal Zuber, Stefan Knackmuss, Clémence Rey, et al.
Pageof 2